US generics manufacturer Par
Pharmaceutical Companies has
announced a definitive agreement
to be acquired by an affiliate of
venture capital firm TPG for $1.9b.
Par also operates Strativa
Pharmaceuticals, developing and
marketing “high barrier-to-entry
generic drugs and niche, innovative
proprietary pharmaceuticals”.The above article was sent to subscribers in Pharmacy Daily's issue from 17 Jul 12 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 17 Jul 12
THOUGH women make up 60% of pharmacy graduates and pharmacists, they hold only 34% of leadership and ownership roles, according to Andria Aird, a community pharmacist, pharmacy owner, and Board Director of Blooms The Chemist.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.